BROADCASTS.com

b'

Dr. Sharmila Anandasabapathy is a professor of\\xa0gastroenterology\\xa0and the director of the Baylor Global Innovation Center in Houston, TX, where she focuses on two broad areas of research: understanding and preventing gastrointestinal (GI) cancers, and addressing leading healthcare challenges worldwide.

Among many topics, Dr. Anandasabapathy discusses the rise of esophageal cancers, the relationship between GI cancers,\\xa0acid reflux, and the Western diet (as well as weight gain and obesity), the importance of endoscopy in the early detection of stomach cancer, and what her team is doing to increase access to portable, battery-operated endoscopic tools for early detection and treatment in under-resourced areas of the world.

Tune in for all the details, and you will learn:

• What the difference is between Barrett\\u2019s esophagus and acid reflux disease
• The different ways of delivering cancer treatments through a scope
• How to identify the early signs of esophageal and stomach cancer
• How the use of\\xa0innovative healthcare apps\\xa0can improve awareness, education, and treatment of GI diseases worldwide
• Risks associated with taking proton pump inhibitors for acid reflux on a long-term basis